Zahoor I, Suhail H, Datta I, Ahmed ME, et al. Blood-based untargeted metabolomics in relapsing-remitting multiple sclerosis revealed the testable therapeutic target. Proc Natl Acad Sci U S A 2022;119:e2123265119.
PMID: 35700359